Living Cell Technologies Limited (LVCLF)

0.0047 0.0000 (0.00%) At close: 01:30PM EDT

Living Cell Technologies Limited

Tower 2
Level 16 Darling Park 201 Sussex Street
Sydney, NSW 2000
Australia
61 3 8689 9997
https://www.lctglobal.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Daya Uka	Chief Financial Officer	121.86k	N/A	N/A
Dr. Belinda Di Bartolo	Chief Operations Officer	101.29k	N/A	N/A
Mr. Mark Andrew Licciardo B Bus (Acc), FCIS, FGIA, GAICD, GradDip CSP	Company Sec.	N/A	N/A	1964
Mr. Madhukar Bhalla	Company Sec.	N/A	N/A	1959

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in Australia and New Zealand. It is developing NTCELL, an alginate-coated capsule, which is in phase IIb clinical trial for the treatment of Parkinson's disease. The company was founded in 1987 and is based in Sydney, Australia.

Corporate governance

Living Cell Technologies Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.